Latest CLBS reports update at 2024-02-29: 20232022
Caladrius Biosciences logo

Caladrius Biosciences CLBS

$ 0.43 -16.75%

Country

usaUSA

IPO year

-

Industry

Biotechnology

Stock Exchange

NASDAQ CAPITAL

CEO

Dr. David Mazzo

Employees in the company

27

Shares

8.07 M

Market Cap[1]

$ 25.8 M

EBITDA (LTM)

$ -57.3 M

P/E (LTM)

-0.04

P/S (LTM)

-

EPS (LTM)

-9.8

Other stocks of industry "Biotechnology"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.